Quanterix Corp (QTRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Quanterix Corp (QTRX) has a cash flow conversion efficiency ratio of -0.131x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-41.25 Million) by net assets ($314.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Quanterix Corp - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Quanterix Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Quanterix Corp for a breakdown of total debt and financial obligations.
Quanterix Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quanterix Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lindsay Australia Ltd
AU:LAU
|
0.093x |
|
Samhwa Paint
KO:000390
|
0.054x |
|
Comstock Holding Companies Inc
NASDAQ:CHCI
|
0.075x |
|
Axactor SE
OL:ACR
|
-0.040x |
|
Woongjin Co Ltd
KO:016880
|
0.275x |
|
Hyloris Developmentsen Sa
BR:HYL
|
-0.058x |
|
Quipt Home Medical Corp
NASDAQ:QIPT
|
0.260x |
|
KEYEAST.Co.Ltd
KQ:054780
|
-0.060x |
Annual Cash Flow Conversion Efficiency for Quanterix Corp (2015–2024)
The table below shows the annual cash flow conversion efficiency of Quanterix Corp from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Quanterix Corp stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $330.04 Million | $-35.16 Million | -0.107x | -97.26% |
| 2023-12-31 | $349.96 Million | $-18.90 Million | -0.054x | +59.95% |
| 2022-12-31 | $357.93 Million | $-48.27 Million | -0.135x | -24.13% |
| 2021-12-31 | $440.95 Million | $-47.91 Million | -0.109x | +4.15% |
| 2020-12-31 | $206.12 Million | $-23.36 Million | -0.113x | +44.31% |
| 2019-12-31 | $128.66 Million | $-26.19 Million | -0.204x | +70.55% |
| 2018-12-31 | $41.56 Million | $-28.72 Million | -0.691x | -105.93% |
| 2017-12-31 | $65.87 Million | $-22.11 Million | -0.336x | +74.51% |
| 2016-12-31 | $13.48 Million | $-17.74 Million | -1.317x | -259.82% |
| 2015-12-31 | $-15.20 Million | $-12.52 Million | 0.824x | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more